Liver and kidney function in Japanese patients with maturity-onset diabetes of the young

Diabetes Care

Volumn 21, Issue 12, 1998, Pages 2144-2148

  Iwasaki, Naoko ^a   Ogata, Makiko ^a   Tomonaga, Osamu ^a   Kuroki, Hlroyuki ^b   Kasahara, Tadasu ^b   Yano, Nobuki ^c   Iwamoto, Yasuhiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Zyousai Hospital   (Japan)

^c Heiwadai Naika Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR FACTOR I;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; JAPAN; KIDNEY FUNCTION; LIVER FUNCTION; MALE; MATURITY ONSET DIABETES MELLITUS; MOLECULAR GENETICS; PANCREAS ISLET BETA CELL; PATHOGENESIS;

EID: 0031767978     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.12.2144     Document Type: Article

References (28)

1. Fajans SS: Scope and heterogeneous nature of MODY Diabetes Care 13:49-64, 1990
2. Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P, Permutt MA, Beckmann JS, Bell GI, Cohen D: Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. N Engl J Med 328:697-702, 1993
3. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI: Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature 384:458-460, 1996
4. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj W, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori H, Takeda J, Fajans SS, HauersJey AT, Iwasaki N, Hansen T, Pedersen O, Polonsky KS, Turner RC, Velho G, Chèvre J-C, Froguel P, Bell GI: Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Mature 384:455-457, 1996
5. Stoffers DA, Ferrer J, Clarke WL, Habener JF: Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 17:138-139, 1997
6. Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockbum BN, Lindner T, Yamagata K, Ogata M, Tomonaga O, Kuroki H, Kasahara T, Iwamoto Y, Bell GI: Mutation in hepatocyte nuclear factor-1β gene (TCF2) associated with maturity-onset diabetes of the young. Nat Genet 17:384-385, 1997
7. Steiner DF, Tager HS, Nanjo K, Chan SJ, Rubenstein AH: Familial syndromes of hyperproinsulinemia and hyperinsulinemia with mild diabetes. In The Metabolic and Molecular Bases of Inherited Disease. 7th ed. Scriver CR, Beaudet AL Sly WS, Valle D, Eds. New York, McGraw-Hill, 1995, p 897-904
8. Herman WH, Fajans SS, Oritz FJ, Smith MJ, Sturis J, Bell GI, Polonsky KS, Halter JB: Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree. Diabetes 43:40-46, 1994
9. Byrne MM, Sturis J, Menzel S, Yamagata K., Fajans SS, Dronsfield MJ, Bain SC, Hattersley AT, Velho G, Froguel P, Bell GI, Polonsky KS: Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes 45:1503-1510, 1996
10. Byrne MM, Stuns J, Clément K, Vionnet N, Pueyo ME, Stoffel M, Takeda J, Passa P, Cohen D, Bell GI, Velho G, Froguel P, Polonsky KS: Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest 93:1120-1130, 1994
11. Velho G, Petersen KF, Perseghin G, Hwang J-H, Rothman DL, Pueyo ME, Cline GW, Froguel P, Shulman GI: Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest 98:1755-1761, 1996
12. Cereghini S: Liver-enriched transcription factors and hepatocyte differentiation. FASEB J 10:267-282, 1996
13. Tronche F, Yaniv M: HNF1, a homeoprotein member of the hepatic transcription regulatory network. BioEssays 14:579-587, 1992
14. Herman WH, Fajans SS, Smith MJ, Polonsky KS, Bell GI, Haker JB: Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4α/MODY1 gene. Diabetes 46:1749-1754, 1997
15. Lindner T, Gragnoli C, Furuta H, Cockburn BN, Petzold C, Rietzsch H, Weiss U, Schulze J, Bell GI: Hepatic function in a family with a nonsense mutation (R154X) in the hepatocyte nuclear factor-4α/MODY1 gene. J Clin Invest 100:1400-1405, 1997
16. Menzel S, Kaisaki P, Menzel R, Rjasanowski I, Sahm J, Ledermann H, Sachse G, Kemer W: Phenotype of human hepatocyte nuclear factor 1α mutations: diabetes, late complications, and glucosuria (Abstract). Diabetologia 40 (Suppl. 1):A161, 1997
17. Pontoglio M, Barra J, Hadchouel M, Doyen A, Kress C, Bach JP, Babinet C, Yaniv M: Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell 84:575-585, 1996
18. Iwasaki N, Oda N, Ogata M, Hara M, Hinokio Y, Oda Y, Yamagata K, Kanematus S, Ohgawara H, Omori Y, Bell GI: Mutations in the hepatocyte nuclear factor-1α/MODY3 gene in Japanese subjects with early- and late-onset NIDDM. Diabetes 46:1504-1508, 1997
19. Furuta H, Iwasaki N, Oda N, Hinokio Y, Horikawa Y, Yamagata K, Yano N, Sugahiro J, Ogata M, Ohgawara H, Omori Y, Iwamoto Y, Bell GI: Organization and partial sequence of the hepatocyte nuclear factor-4α/MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY. Diabetes 46:1652-1657, 1997
20. Fajans SS, Conn JW: Prediabetes, subclinical diabetes, and lacent diabetes: interpretation, diagnosis and treatment. In On the Nature and Treatment of Diabetes. Leibel DS, Wrenshall GS, Eds. Amsterdam, Excerpta Medica, 1965, p. 641-656
21. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
22. Ledermann HM: Is maturity onset diabetes at young age (MODY) more common in Europe than previously assumed? (Letter) Lancet 345:648, 1995
23. Yamada S, Nishigori H, Onda H, Utsugi T, Yanagawa T, Maruyama T, Onigata K, Nagashima K, Nagai R, Morikawa A, Takeuchi T, Takeda J: Identification of mutations in the hepatocyte nuclear factor (HNF)-1α gene in Japanese subjects with IDDM. Diabetes 46:1643-1647, 1997
24. Tronche F, Ringeisen F, Blumenfeld M, Yaniv M, Pontoglio M: Analysis of the distribution of binding sites for a tissue-specific transcription factor in the vertebrate genome. J Mol Biol 266:231-245, 1997
25. Reaven GM: Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
26. Velho G, Vaxillaire M, Boccio V, Charpentier G, Froguel P: Diabetes complications in NIDDM kindreds linked to the MODY3 locus on chromosome 12q. Diabetes Care 19:915-919, 1996
27. Isomaa B, Henricsson M, Lehto M, Forsblom C, Karanko S, Sarelin L, Häggblom M, Groop L: Chronic diabetic complications in patients with MODY3 diabetes. Diabetologia 41:467-473, 1998
28. Nishigori H, Yamada S, Kohama T, Tomura H, Sho K, Horikawa Y, Bell GI, Takeuchi T, Takeda J: Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1β gene associated with diabetes and renal dysfunction. Diabetes 47:1354-1355, 1998